Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Wada

Showing results (161-170 of 198) with videos related to

Pageof 20
Sort By:
Cancer Genomics & Proteomics|December 27, 2024
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint InhibitorsTomoyuki Ishiguro, Kazuyuki Takeda, Daisuke Takayanagi, et al.
Frontiers in Immunology|December 29, 2025
Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire studyHirotsugu Ariizumi, Miyuki Shimazui, Chisato Ogawa, et al.
Scientific Reports|September 29, 2025
Maternal administration of octanoate, a medium-chain fatty acid, improves feed efficiency of Japanese black calves through influencing gut bacteriome structureHaruki Yamano, Hiroshi Horike, Yutaka Taguchi, et al.
Medicine|January 14, 2022
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case reportKazuyuki Hamada, Kiyoshi Yoshimura, Kazuhiko Oshinomi, et al.
Biomedicines|December 24, 2021
Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 AntibodiesRyotaro Ohkuma, Katsuaki Ieguchi, Makoto Watanabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cellsDerese Getnet, Charles H Maris, Edward L Hipkiss, et al.
Frontiers in Oncology|October 28, 2024
Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patientsYuya Hirasawa, Yutaro Kubota, Emiko Mura, et al.
Anticancer Research|July 26, 2024
Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to TreatmentYuya Hirasawa, Yutaro Kubota, Emiko Mura, et al.
Cancer Science|June 18, 2019
Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy seriesTerufumi Kubo, Giichiro Tsurita, Yoshihiko Hirohashi, et al.
Environmental Research|December 23, 2022
Computational estimation of sediment symbiotic bacterial structures of seagrasses overgrowing downstream of onshore aquacultureHirokuni Miyamoto, Nobuhiro Kawachi, Atsushi Kurotani, et al.
Pageof 20

Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Cancer Genomics & Proteomics|December 27, 2024
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint InhibitorsTomoyuki Ishiguro, Kazuyuki Takeda, Daisuke Takayanagi, et al.
Frontiers in Immunology|December 29, 2025
Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire studyHirotsugu Ariizumi, Miyuki Shimazui, Chisato Ogawa, et al.
Scientific Reports|September 29, 2025
Maternal administration of octanoate, a medium-chain fatty acid, improves feed efficiency of Japanese black calves through influencing gut bacteriome structureHaruki Yamano, Hiroshi Horike, Yutaka Taguchi, et al.
Medicine|January 14, 2022
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case reportKazuyuki Hamada, Kiyoshi Yoshimura, Kazuhiko Oshinomi, et al.
Biomedicines|December 24, 2021
Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 AntibodiesRyotaro Ohkuma, Katsuaki Ieguchi, Makoto Watanabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cellsDerese Getnet, Charles H Maris, Edward L Hipkiss, et al.
Frontiers in Oncology|October 28, 2024
Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patientsYuya Hirasawa, Yutaro Kubota, Emiko Mura, et al.
Anticancer Research|July 26, 2024
Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to TreatmentYuya Hirasawa, Yutaro Kubota, Emiko Mura, et al.
Cancer Science|June 18, 2019
Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy seriesTerufumi Kubo, Giichiro Tsurita, Yoshihiko Hirohashi, et al.
Environmental Research|December 23, 2022
Computational estimation of sediment symbiotic bacterial structures of seagrasses overgrowing downstream of onshore aquacultureHirokuni Miyamoto, Nobuhiro Kawachi, Atsushi Kurotani, et al.
Pageof 20